@inproceedings{oai:repo.qst.go.jp:00054208,
 author = {Kamada, Tadashi and Sugahara, Shinji and Tsuji, Hiroshi and Serizawa, Itsuko and Imai, Reiko and Okada, Tohru and Tsujii, Hirohiko and 鎌田 正 and 菅原 信二 and 辻 比呂志 and 芹澤 慈子 and 今井 礼子 and 岡田 徹 and 辻井 博彦},
 book = {NIRS-IMP Joint Symposium on Carbon Ion Therapy},
 issue = {225},
 month = {Aug},
 note = {The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2008, a total of 421 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities.},
 pages = {37--43},
 publisher = {National Institute of Radiological Science},
 title = {Carbon Ion Radiotherapy in Bone and Soft Tissue Sarcomas},
 volume = {NIRS-M},
 year = {2009}
}